Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)

SHA:600664 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3,385	3,437	3,634	3,060	2,433	1,592
Cash & Short-Term Investments	3,385	3,437	3,634	3,060	2,433	1,592
Cash Growth	10.87%	-5.44%	18.75%	25.76%	52.85%	77.49%
Accounts Receivable	5,202	4,748	4,985	4,961	4,818	4,749
Other Receivables	137.03	129.57	130.8	146.47	178.51	85.86
Receivables	5,340	4,878	5,116	5,107	4,997	4,835
Inventory	1,965	2,061	1,891	1,924	1,804	2,064
Prepaid Expenses	3.87	6.82	9.67	10.7	4.93	-
Other Current Assets	362.15	270.93	327.8	293.61	320.05	242.45
Total Current Assets	11,055	10,653	10,979	10,396	9,560	8,733
Property, Plant & Equipment	2,286	2,338	2,385	2,468	2,641	2,835
Long-Term Investments	31.06	31.06	33.49	38.42	37.62	39.32
Goodwill	39.16	39.16	39.16	39.15	39.15	39.15
Other Intangible Assets	421.73	411.55	408.4	451.14	444.21	480.78
Long-Term Deferred Tax Assets	610.68	607.84	603.74	597.85	600.19	599.44
Long-Term Deferred Charges	78.02	88.53	63.4	41.29	63.96	71.76
Other Long-Term Assets	113.81	118.59	104.24	80.16	48.84	44.11
Total Assets	14,635	14,288	14,616	14,112	13,435	12,842

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3,812	4,032	4,039	3,951	3,510	3,482
Accrued Expenses	570.66	602.44	618.37	597.07	668.02	628.3
Short-Term Debt	1,101	1,041	1,554	1,658	1,933	2,078
Current Portion of Long-Term Debt	105.83	105.47	104.76	104.04	103.64	102.92
Current Portion of Leases	29.24	27.76	36.23	31.21	35.93	36.74
Current Income Taxes Payable	60.13	43.91	57.21	80.1	98.29	85.17
Current Unearned Revenue	140.12	130.74	311.61	282.45	235.87	119.73
Other Current Liabilities	1,514	1,439	1,383	1,539	1,417	1,322
Total Current Liabilities	7,334	7,423	8,105	8,243	8,002	7,855
Long-Term Debt	31.55	31.48	31.7	32.63	33.19	34.09
Long-Term Leases	38.61	30.16	35.32	31.08	43.68	61.61
Long-Term Unearned Revenue	295.6	290.97	300.74	319.07	333.61	375.1
Long-Term Deferred Tax Liabilities	8.73	7.59	5.73	6.91	6.29	1.68
Other Long-Term Liabilities	42.78	42.78	47.98	56.64	69.7	94.7
Total Liabilities	7,751	7,826	8,526	8,689	8,488	8,422

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2,519	2,519	2,519	2,521	2,526	2,518
Additional Paid-In Capital	670.27	663.33	684.11	685.32	688.6	675.43
Retained Earnings	4,682	4,272	3,911	3,282	2,887	2,426
Treasury Stock	-	-	-	-3.98	-13.01	-15.53
Comprehensive Income & Other	-1,765	-1,766	-1,763	-1,760	-1,760	-1,757
Total Common Equity	6,106	5,688	5,350	4,724	4,328	3,847
Minority Interest	778.71	774	739.49	698.75	618.87	573.25
Shareholders' Equity	6,885	6,462	6,089	5,423	4,947	4,420
Total Liabilities & Equity	14,635	14,288	14,616	14,112	13,435	12,842

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,307	1,236	1,762	1,857	2,149	2,313
Net Cash (Debt)	2,078	2,201	1,872	1,203	284.1	-720.94
Net Cash Growth	19.00%	17.58%	55.56%	323.57%	-	-
Net Cash Per Share	0.80	0.85	0.74	0.49	0.11	-0.29
Filing Date Shares Outstanding	2,519	2,519	2,519	2,521	2,526	2,518
Total Common Shares Outstanding	2,519	2,519	2,519	2,521	2,526	2,518
Working Capital	3,721	3,230	2,874	2,153	1,558	878.23
Book Value Per Share	2.42	2.26	2.12	1.87	1.71	1.53
Tangible Book Value	5,645	5,237	4,902	4,234	3,844	3,327
Tangible Book Value Per Share	2.24	2.08	1.95	1.68	1.52	1.32
Buildings	4,591	4,603	4,659	4,644	4,702	4,683
Machinery	2,919	3,362	3,308	3,214	3,169	3,545
Construction In Progress	80.54	65.56	74.73	69.12	66.22	164.92

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error